# Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents

> **NCT00207948** · — · TERMINATED · sponsor: **Children's National Research Institute** · enrollment: 4 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Dose adjustment of Kaletra

## Key facts

- **NCT ID:** NCT00207948
- **Lead sponsor:** Children's National Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2004-11
- **Primary completion:** 2009-05
- **Final completion:** 2009-07
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** no measurable response was detected at the 50% increase threshold.
- **Last updated:** 2015-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00207948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00207948, "Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00207948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*